News

EFPIA has issued a new statement on the EFPIA-PhRMA Principles for Responsible Clinical Trials Data Sharing

An independent Data and Safety Monitoring Board has completed the successful review of the safety data of the Phase IIb clinical trial of TNF-Kinoid in rheumatoid arthritis

Camargo Pharmaceutical Services has tapped academic organizations close to its Raleigh, NC site in a unique internship program...

With the joint release and agreement of the PhRMA and EFPIA on those organizations clinical trial data sharing and transparency principles, BIO has releases its own Principles on Clinical Trial Data Sharing.

Medesis Pharma has signed a collaboration agreement with the French Commission for Atomic Energy and Alternative Energies

Innovative partner network to facilitate integration of digital patient engagement and data capture in clinical research programs

Camargo Pharmaceutical Services is adding expertise to its projects and helping postdoctoral researchers gain real-world experience through a unique internship program.

I've notice of late quite of lot of confusion over the approval requirements that apply when using mobile devices in clinical trials.

The Biotechnology Industry Organization today reaffirmed and broadened its long-standing commitment to improving human health...

NEOVACS announced its financial results for the year to 31 December 2013 as approved by the Board of Directors on March 26th 2014.

Novel scientific collaboration to use genomics and big data to drive drug discovery

MedNet will once again be participating in the Partnerships in Clinical Trials conference.

A public-private research initiative between GSK, the European Bioinformatics Institute and the Wellcome Trust Sanger Institute aims to harness the power of "big data" and genome sequencing to improve the success rate for discovering new medicines.

As payers demand more evidence documenting medical product value, biopharma companies are responding by moving sooner to decide key clinical outcomes to measure.

The global orphan drugs market presents many opportunities for new drug development...

PCORI has appointed 10 members to its new Advisory Panel on Clinical Trials

PCORI has launched its Matchmaking App Challenge

Panel Will Provide Expertise on Trial Selection, Design and Implementation

PCORI Offers $150,000 in Prizes to Develop Research Relationship-Building Apps

Frost & Sullivan: Breakthrough therapies for rare diseases command premium pricing, particularly if no alternatives exist

New investments in facilities and scientific leadership reflect Covance?s commitment to biologics development

Oracle announced its Clinical Monitoring Cloud

Covance announced it is expanding its large molecule bioanalytical space

PHT Corporation is offering an app based on the FDA's Clinical Outcome Assessment Qualification Program

The shift to personalized medicine has been hindered by uncertainty over the value, accuracy, and clinical utility of companion diagnostic tests.

Adaptive licensing has leapt from the pages of learned journals into the real world of European regulation.

The last decade has seen the complexity, size, and costs of clinical trials increase, which has made the task of guaranteeing data quality progressively difficult.

The FDA Roadmap enables researchers involved in patient-centric trials to navigate FDA clinical outcome assessment qualification program

Mosio has launched an eBook "Clinical Trials Patient Recruiting and Retention: Tips for Success."